Fu-Shing Liu

950 total citations
20 papers, 710 citations indexed

About

Fu-Shing Liu is a scholar working on Reproductive Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Fu-Shing Liu has authored 20 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Reproductive Medicine, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Fu-Shing Liu's work include Ovarian cancer diagnosis and treatment (9 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Uterine Myomas and Treatments (3 papers). Fu-Shing Liu is often cited by papers focused on Ovarian cancer diagnosis and treatment (9 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Uterine Myomas and Treatments (3 papers). Fu-Shing Liu collaborates with scholars based in Taiwan and United States. Fu-Shing Liu's co-authors include Esther Shih‐Chu Ho, Chien‐Hsing Lu, Man‐Jung Hung, Jung‐Ta Chen, Yeun-Ting Hsieh, Jin‐Tang Dong, Tao‐Yeuan Wang, Mu-Hsien Yu, Tze-Chien Chen and Chian‐Jue Kuo and has published in prestigious journals such as Cancer, Obstetrics and Gynecology and Gynecologic Oncology.

In The Last Decade

Fu-Shing Liu

19 papers receiving 693 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fu-Shing Liu Taiwan 13 313 232 201 161 103 20 710
Isabelle Matte Canada 20 514 1.6× 365 1.6× 424 2.1× 57 0.4× 50 0.5× 22 1.2k
Hye Sook Chon United States 16 213 0.7× 211 0.9× 222 1.1× 135 0.8× 48 0.5× 68 680
Evelien W. Duiker Netherlands 14 332 1.1× 108 0.5× 345 1.7× 68 0.4× 51 0.5× 26 750
Y Tenjin Japan 11 184 0.6× 101 0.4× 117 0.6× 64 0.4× 82 0.8× 38 488
Suet‐Ying Kwan United States 13 821 2.6× 95 0.4× 160 0.8× 31 0.2× 101 1.0× 24 1.1k
Ainura Kyshtoobayeva United States 13 441 1.4× 54 0.2× 420 2.1× 23 0.1× 25 0.2× 18 859
Po‐Hsuan Su Taiwan 18 591 1.9× 93 0.4× 203 1.0× 94 0.6× 200 1.9× 33 923
Rui Shi China 15 350 1.1× 87 0.4× 88 0.4× 83 0.5× 18 0.2× 40 682

Countries citing papers authored by Fu-Shing Liu

Since Specialization
Citations

This map shows the geographic impact of Fu-Shing Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu-Shing Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu-Shing Liu more than expected).

Fields of papers citing papers by Fu-Shing Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fu-Shing Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu-Shing Liu. The network helps show where Fu-Shing Liu may publish in the future.

Co-authorship network of co-authors of Fu-Shing Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Fu-Shing Liu. A scholar is included among the top collaborators of Fu-Shing Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fu-Shing Liu. Fu-Shing Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Fu-Shing, et al.. (2022). Uterine smooth muscle tumor of uncertain malignant potential: A review of current knowledge. Taiwanese Journal of Obstetrics and Gynecology. 61(6). 935–940. 6 indexed citations
2.
Liu, Fu-Shing, et al.. (2011). Antrodia camphorata Induces Apoptosis and Enhances the Cytotoxic Effect of Paclitaxel in Human Ovarian Cancer Cells. International Journal of Gynecological Cancer. 21(7). 1172–1179. 20 indexed citations
3.
Ho, Chih‐Ming, Wen‐Fang Cheng, Ming-Chieh Lin, et al.. (2010). Prognostic and predictive values of E-cadherin for patients of ovarian clear cell adenocarcinoma.. PubMed. 20(9). 1490–7. 20 indexed citations
4.
Liu, Fu-Shing. (2009). Mechanisms of Chemotherapeutic Drug Resistance in Cancer Therapy—A Quick Review. Taiwanese Journal of Obstetrics and Gynecology. 48(3). 239–244. 164 indexed citations
5.
Liu, Fu-Shing, Yee‐Jee Jan, Chiung‐Ru Lai, et al.. (2008). Expression Analysis of Apoptosis-related Markers TP53, BCL-2, BAX and c-MYC in Female Genital Tract Sarcomas. Journal of the Chinese Medical Association. 71(12). 628–634. 11 indexed citations
6.
Liu, Fu-Shing. (2007). Molecular Carcinogenesis of Endometrial Cancer. Taiwanese Journal of Obstetrics and Gynecology. 46(1). 26–32. 94 indexed citations
7.
Lu, Chien‐Hsing, Fu-Shing Liu, Chian‐Jue Kuo, Chia‐Che Chang, & Esther Shih‐Chu Ho. (2006). Prediction of Persistence or Recurrence After Conization for Cervical Intraepithelial Neoplasia III. Obstetrics and Gynecology. 107(4). 830–835. 51 indexed citations
8.
Lin, Chia‐Hui, Fu-Shing Liu, & Esther Shih‐Chu Ho. (2006). Transitional Cell Carcinoma of the Ovary. Taiwanese Journal of Obstetrics and Gynecology. 45(3). 268–271. 21 indexed citations
9.
Chen, Gin‐Den, et al.. (2005). Genetic Changes in Ovarian Cancer. Taiwanese Journal of Obstetrics and Gynecology. 44(3). 218–231. 2 indexed citations
10.
Chen, Gin‐Den, et al.. (2005). Mechanisms Involved in Chemoresistance in Ovarian Cancer. Taiwanese Journal of Obstetrics and Gynecology. 44(3). 209–217. 15 indexed citations
11.
Chen, Yu‐Ju, Esther Shih‐Chu Ho, & Fu-Shing Liu. (2005). Extrauterine Low-Grade Endometrial Stromal Sarcoma. Taiwanese Journal of Obstetrics and Gynecology. 44(4). 387–390.
12.
Liu, Fu-Shing, et al.. (2004). Management of Pelvic Lymphocysts by Ultrasound-Guided Aspiration and Minocycline Sclerotherapy. Gynecologic and Obstetric Investigation. 59(3). 130–133. 6 indexed citations
13.
Ho, Chih‐Ming, Ruby Yun‐Ju Huang, Tze-Chien Chen, et al.. (2004). Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease. Gynecologic Oncology. 94(1). 197–203. 84 indexed citations
14.
15.
Liu, Fu-Shing, Jung‐Ta Chen, Yeun-Ting Hsieh, et al.. (2003). Loss of Smad4 Protein Expression Occurs Infrequently in Endometrial Carcinomas. International Journal of Gynecological Pathology. 22(4). 347–352. 11 indexed citations
16.
Liu, Fu-Shing, Jin‐Tang Dong, Jung‐Ta Chen, et al.. (2003). KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer.. PubMed. 9(4). 1393–8. 34 indexed citations
17.
Ho, Esther Shih‐Chu, Chiung‐Ru Lai, Yeun-Ting Hsieh, et al.. (2001). p53 Mutation Is Infrequent in Clear Cell Carcinoma of the Ovary. Gynecologic Oncology. 80(2). 189–193. 62 indexed citations
18.
Lu, Chien‐Hsing, Fu-Shing Liu, Jenn-Jhy Tseng, & Esther Shih‐Chu Ho. (2000). Predictive Factors for Residual Disease in Subsequent Hysterectomy Following Conization for CIN III. Gynecologic Oncology. 79(2). 284–288. 38 indexed citations
19.
Liu, Fu-Shing, Jin‐Tang Dong, Jung‐Ta Chen, et al.. (2000). Frequent Down-Regulation and Lack of Mutation of the KAI1 Metastasis Suppressor Gene in Epithelial Ovarian Carcinoma. Gynecologic Oncology. 78(1). 10–15. 53 indexed citations
20.
Liu, Fu-Shing, et al.. (1995). Overexpression or mutation of the p53 tumor suppressor gene does not occur in malignant ovarian germ cell tumors. Cancer. 76(2). 291–295. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabelle Matte Breakdown of academic impact, for papers by Hye Sook Chon Breakdown of academic impact, for papers by Evelien W. Duiker Breakdown of academic impact, for papers by Y Tenjin Breakdown of academic impact, for papers by Suet‐Ying Kwan Breakdown of academic impact, for papers by Ainura Kyshtoobayeva Breakdown of academic impact, for papers by Po‐Hsuan Su Breakdown of academic impact, for papers by Rui Shi
Rankless by CCL
2026